| Literature DB >> 25966959 |
Zhong-fei Xu1,2, Wei-yi Duan3,4, En-jiao Zhang5,6, Shuang Bai7,8, Yu Tian9,10, Xue-xin Tan11,12, Fa-yu Liu13,14, Chang-fu Sun15,16.
Abstract
BACKGROUND: The purpose of this study was to investigate the reliability and outcome of using the transverse cervical vessel (TCV) as a recipient vessel for microvascular reconstruction in patients whose vessels in the neck region are unavailable because of previous surgery or radiotherapy.Entities:
Mesh:
Year: 2015 PMID: 25966959 PMCID: PMC4485336 DOI: 10.1186/s12957-015-0576-8
Source DB: PubMed Journal: World J Surg Oncol ISSN: 1477-7819 Impact factor: 2.754
Patient characteristics
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|
| 1 | 42/F | SCC of the lower gingiva | Maxillectomy | uni | Y | None | ALT | 9 | None |
| 2 | 36/F | ACC of FOM (recurrence) | Resection ACC FOM | bil | Y | MSAP | ALT | 15 | Delayed wound healing |
| 3 | 59/M | ACC of the mandible (recurrence) | Marginal resection of the mandible | bil | N | Plastyma | Fibula | 10 | None |
| 4 | 65/M | SCC of the tongue (second primary cancer) | Resection SCC of FOM | bil | Y | ALT | AMT | 10 | None |
| 5 | 60/F | SCC of the lower gingiva (recurrence) | Hemimandibulectomy | uni | N | Fibula | ALT + AMT | 19 | None |
| 6 | 49/F | Mouth opening limited | Maxillectomy | uni | N | None | ALT | 18 | Fistula and delayed wound healing |
| 7 | 58/M | SCC of buccal mucosa (recurrence) | Resection SCC of buccal mucosa | uni | Y | None | ALT | 9 | None |
| 8 | 69/F | SCC of buccal mucosa (recurrence) | Resection SCC of buccal mucosa | uni | Y | None | ALT | 10 | None |
SND, selective neck dissection; RT, radiotherapy; SCC, squamous cell carcinoma; uni, unilateral; ALT, anterolateral thigh flap; ACC, adenoid cystic carcinoma; FOM, floor of mouth; bil, bilateral; MSAP, medial sural artery perforator flap; AMT, anteromedial thigh flap; F, female; M, male.
Figure 1Preoperatively marked recipient vessels and designed the transverse incision parallel to the clavicle to enable exploration of TCVs. SCM, sternocleidomastoid muscle; EJV, external jugular vein.
Figure 2The right TCVs, located 2 cm above the clavicle and lateral to the SCM, were exposed. SCM, sternocleidomastoid muscle; EJV, external jugular vein.
Role of the TCVs
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|
| 1 | 42/F | TCA/TCV | E-E | 38 | 24 | 172 | 8.8 | 6.1 | 9.7 |
| 2 | 36/F | TCA/IJV | E-S | 33 | 20 | 135 | 8.2 | 6.3 | 10.3 |
| 3 | 59/M | TCA/TCV | E-E | 42 | 25 | 170 | 11.3 | 8.1 | 7.5 |
| 4 | 65/M | TCA/TCV | E-E | 35 | 17 | 193 | 11.2 | 9.3 | 10.1 |
| 5 | 60/F | TCA/EJV | E-E | 45 | 15 | 157 | 10.2 | 8.5 | 10.8 |
| 6 | 49/F | TCA/TCV | E-E | 23 | 15 | 133 | 12.1 | 9.4 | 11.5 |
| 7 | 58/M | TCA/TCV | E-E | 75 | 18 | 135 | 15 | 10 | 15 |
| 8 | 66/F | TCA/TCV | E-E | 45 | 12 | 195 | 12.4 | 11 | 13 |
aDistance refers to bridging distance between the acceptor site and recipient vessel site, bDistance refers to bridging distance between the acceptor site and anastomosis site. F, female; M, male; E-E, end to end; E-S, end to side; TCA, transverse cervical artery; TCV, transverse cervical vein; IJV, internal jugular vein; EJV, external jugular vein.
Figure 3Case presentation (patient 4): a second primary carcinoma occurred in the tongue (R) 18 months after the first reconstruction with an ALT flap.
Figure 4Case presentation (patient 4): the healed flap on the tongue after the 6-month follow-up. AMT, anteromedial thigh flap; ALT, anterolateral thigh flap.